| |
| |
|
| Insider
Information: |
Murphy Nicole |
| Relationship: |
Head of Pharm Ops and ... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
9,634 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,012,543 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
9,634 |
|
|
| Total
Value |
$2,012,543 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Head of Pharm Ops and ... |
2024-04-01 |
9,634 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2024-04-01 |
4 |
D |
$214.83 |
$25,135 |
D/D |
(117) |
9,634 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
240 |
9,751 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2024-02-16 |
4 |
D |
$219.08 |
$133,639 |
D/D |
(610) |
9,418 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,260 |
9,614 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2024-02-09 |
4 |
D |
$240.98 |
$183,386 |
D/D |
(761) |
8,768 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2024-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,272 |
9,529 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2024-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,101 |
7,895 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2024-02-08 |
4 |
D |
$240.30 |
$153,311 |
D/D |
(638) |
7,257 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2023-02-17 |
4 |
D |
$278.38 |
$64,863 |
D/D |
(233) |
5,099 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2023-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
480 |
5,579 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2023-02-10 |
4 |
D |
$286.30 |
$397,098 |
D/D |
(1,387) |
5,332 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,611 |
6,034 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2023-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,340 |
4,108 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2022-12-02 |
4 |
D |
$298.90 |
$11,657 |
D/D |
(39) |
2,768 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2022-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
131 |
2,807 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2022-08-01 |
4 |
D |
$209.26 |
$66,754 |
D/D |
(319) |
2,676 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2022-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,080 |
2,919 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2022-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
239 |
1,897 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2022-04-01 |
4 |
D |
$210.65 |
$17,695 |
D/D |
(84) |
1,813 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2022-02-18 |
4 |
D |
$209.79 |
$23,077 |
D/D |
(110) |
1,658 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
371 |
1,768 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2022-02-12 |
4 |
D |
$214.59 |
$19,742 |
D/D |
(92) |
1,397 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and Tech |
• • – |
2022-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
263 |
1,489 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Pharm Ops and TechOffi |
• – – |
2022-02-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,225 |
|
% |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
